library.onepin.app/hypness-blend Peptide Education Library
Education only, not medical advice 21+ Every dose is an example to finalize with a licensed provider

OnePin Peptide Library · Cognitive & Mood

Cognitive & Mood Pre-mixed sleep and GH recovery blend Not FDA-approved · investigational

Hypness Blend

Hypness Stack · Hypness

Pre-mixed sleep and GH recovery blendDSIP + Selank + CJC-1295 no DAC + Ipamorelin combinationSleep architecture optimizerGrowth hormone secretagogue stack

The Hypness Blend is a four-peptide sleep and GH recovery combination containing DSIP 5mg, Selank 5mg, CJC-1295 no DAC 6mg, and Ipamorelin 12mg for a total of 28mg per vial in 5mL. This blend targets two complementary nighttime systems simultaneously: sleep architecture optimization through DSIP and Selank, and growth hormone release through the CJC/Ipamorelin GHRH+GHRP axis. The result is a single bedtime injection that promotes deep restorative sleep while maximizing the nocturnal GH pulse that naturally peaks during slow-wave sleep.

Quick Start
Route
Subcutaneous (SubQ) injection, abdomen
Start low
100-200mcg Ipamorelin equivalent (low end of vial ratio)
Frequency
Nightly, 30-60 minutes before bedtime
Timing
Fasted 2+ hours. GH release from CJC/Ipamorelin is blunted by food.

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first
Quick Start
Conservative start
100-200mcg Ipamorelin equivalent (low end of vial ratio) · Subcutaneous (SubQ) injection, abdomen · Nightly, 30-60 minutes before bedtime
Lowest starting point. Hold about a week to assess tolerance before stepping up.
100-200mcg Ipamorelin equivalent (low end of vial ratio)
Nightly, 30-60 minutes before bedtime
Intermediate
Deep Sleep Peptide Synergy
500-1000 mcg total · SubQ · Daily
anecdotal · community
500-1000 mcg total
Daily
Reconstitution CalculatorU-100
050100u
Draw to
units
01

How it works

The Hypness Blend works through four complementary mechanisms timed for bedtime administration:

The Hypness Blend works through four complementary mechanisms timed for bedtime administration:

DSIP Component (5mg): Enhances GABAergic inhibitory tone to promote sleep onset and maintenance, normalizes cortisol circadian rhythm (reducing evening cortisol that interferes with sleep), and modulates serotonin metabolism affecting sleep-wake transitions. DSIP forms complexes with carrier proteins that serve as slow-release reservoirs, extending its effective window through the night despite a short plasma half-life.

Selank Component (5mg): Modulates GABA-A receptor sensitivity without directly binding the benzodiazepine site, providing anxiolytic calming without sedation or dependence. Also influences serotonin metabolism to stabilize mood and reduce pre-sleep anxiety. The tuftsin-derived immunomodulatory activity provides additional immune support during the sleep recovery window.

CJC-1295 no DAC Component (6mg): Binds GHRH receptors on pituitary somatotrophs, activating cAMP/PKA signaling to prime GH release. The ~30 minute half-life produces an acute GH pulse that aligns with the natural nocturnal GH surge during slow-wave sleep.

Ipamorelin Component (12mg): Selectively activates ghrelin receptors (GHS-R1a) on the pituitary through a separate intracellular pathway from CJC. The dual GHRH + GHRP stimulation produces synergistic GH pulses 3-5x greater than either alone. Ipamorelin does not significantly affect cortisol, prolactin, or appetite at standard doses.

Synergy: DSIP and Selank deepen sleep, creating optimal conditions for GH release. CJC and Ipamorelin amplify the nocturnal GH pulse that naturally peaks during the deep sleep promoted by DSIP. The result is a reinforcing cycle where deeper sleep enables greater GH output, and elevated GH further supports restorative sleep processes.

02

What to expect

Early
Days 1–7

Days 1-7: Selank anxiolytic effects often noticeable from the first dose, with reduced pre-sleep anxiety and faster sleep onset. DSIP delta wave promotion begins shifting sleep architecture toward deeper stages within 2-3 nights. Some users report more vivid dreams. CJC/Ipa GH pulses begin immediately but body composition changes are not yet visible. Mild injection site redness may occur.

Mid
Weeks 2–4

Weeks 2-4: Sleep quality improvements become consistent and pronounced. Delta wave sleep duration increases measurably. Morning recovery feeling markedly improved. GH-mediated benefits begin emerging: improved skin quality, better workout recovery, subtle body composition shifts. Cortisol rhythm normalization from DSIP contributes to improved daytime energy.

Later
Weeks 4–12

Weeks 4-12: Full cumulative benefits realized. Sleep architecture remodeled with sustained deep sleep improvement. Body composition changes visible from consistent nocturnal GH elevation. Recovery capacity noticeably enhanced. Consider cycling off after 8-12 weeks with a 4-week break to maintain receptor sensitivity for both the GH axis and sleep peptides.

03

Evidence

HumanModerate
AnimalPresent
In-vitroPresent
2010DSIP (Delta Sleep-Inducing Peptide) clinical sleep effects ·
2015Selank anxiolytic and cognitive effects ·
2010CJC-1295 / Ipamorelin GH-axis activation ·
04

The honest take

Single bedtime injection optimizes both sleep architecture and nocturnal GH release

Plausible

Mechanistically plausible. DSIP promotes delta wave sleep, and GH is naturally released during slow-wave sleep. CJC/Ipa stimulates GH release. The synergy between deeper sleep and pharmacological GH stimulation is a reasonable hypothesis but has not been directly measured with this combination.

DSIP promotes delta wave slow-wave sleep
Partly true

Partially supported. Human studies from the 1980s-1990s showed some delta wave promotion, but results were inconsistent across studies. The evidence base is limited by small sample sizes and dated methodology. Animal data is more consistent.

Selank provides benzodiazepine-level anxiolysis without sedation or dependence

Supported by Russian clinical trials comparing Selank to medazepam. Selank showed comparable anxiolytic effects without the sedation, cognitive impairment, or dependence risk. These trials have limited Western peer review but represent meaningful clinical data.

05

Interactions & stacking

What's safe to combine, and what belongs in a separate pin.

Safe & synergistic

AOD-9604Fat metabolism peptide. No interaction with sleep or GH secretagogue components. Safe in same syringe.
KPVAnti-inflammatory tripeptide. No reactive residue conflicts. Safe in same syringe.
SS-31Mitochondrial peptide. Different pathway. Safe in same syringe.
PinealonComplementary pineal support for melatonin production. No residue conflicts.

Keep separate

LL-37DSIP is anionic. LL-37 is cationic (+6 charge). Electrostatic charge interaction causes aggregation on contact. NEVER combine.
CJC-1295 with DACDAC maleimide linker may react with peptides in syringe. Also, CJC with DAC provides continuous GH elevation rather than pulsatile release, undermining the sleep-aligned pulse strategy.
NAD+Acidic pH of NAD+ can denature peptides in the blend. Different routes anyway (NAD+ is typically IM).
GlutathioneThiol chemistry may interfere with peptide stability. Pin separately.
06

Side effects & safety

Commonly reported

  • Vivid dreams or increased dream recall (DSIP effect)
  • Mild injection site redness or warmth
  • Occasional lightheadedness immediately post-injection
  • Slight numbness or tingling in extremities from GH pulse (water retention)
  • Mild morning grogginess during first few days of DSIP adjustment

Less common & notes

  • Rarely reported: transient nausea, headache, temporary water retention from GH elevation.
  • Ipamorelin is the cleanest GHRP with minimal cortisol or prolactin stimulation.
  • DSIP and Selank have favorable safety profiles.
  • Long-term human safety data for this specific combination does not exist.
07

Pharmacokinetics

Illustrative plasma concentration · 24 h
Half-life
DSIP: ~15 min (plasma, extended by carrier proteins); Selank: ~30 min; CJC-1295 no DAC: ~30 min; Ipamorelin: ~2 hours
Peak · Tmax
DSIP: ~30 min; Selank: ~45 min; CJC-1295 no DAC: ~15 min; Ipamorelin: ~40 min
Elimination
DSIP: ~1.25 hours (plasma); Selank: ~2.5 hours; CJC-1295 no DAC: ~2.5 hours; Ipamorelin: ~10 hours
Activity
DSIP: 6-8 hours (sleep effects through the night via carrier protein depot); Selank: 6-12 hours; CJC/Ipa GH pulse: 1-3 hours (GH/IGF-1 elevation persists several hours beyond)

Storage. Reconstitute with bacteriostatic water. Store refrigerated at 2-8 degrees C. Shelf life approximately 28 days after reconstitution. Do not freeze after reconstitution. Protect from light. Discard if cloudy or particulate matter visible. The multi-component nature of this blend means stability is limited by the least stable component.

08

Regulatory status

Not FDA-approved. Available through compounding pharmacies and research suppliers. Selank and Semax are approved medications in Russia. DSIP, CJC-1295 no DAC, and Ipamorelin are classified as research peptides. Ipamorelin has undergone Phase 1-2 human trials. All use of this blend is experimental and off-label.

Put it to work

Calculate, log & track

Open Hypness Blend straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open Hypness Blend in the app →

Go deeper

The guide & community

The complete Hypness Blend walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗
Open in app Community